We came across a bullish thesis on Baxter International Inc. on DeepValue Capital’s Substack. In this article, we will ...

Stifel downgraded Baxter International to ‘Hold’ from ‘Buy’ and slashed the price target to $25 from $36. The analysts ...

Baxter International slashed its 2025 profit forecast and posted disappointing quarterly earnings on Thursday, as lingering ...

While Baxter International has lagged the broader market over the past year, Wall Street analysts remain cautiously ...

Deerfield-based Baxter International is still feeling battered by Hurricane Helene and problems with its Novum infusion pumps ...

Detailed price information for Baxter International Inc (BAX-N) from The Globe and Mail including charting and trades.

Baxter International (NYSE:BAX) stock drops after the company's Q2 results miss consensus and Q3 projection fails to meet ...

Baxter International cut its 2025 profit forecast on Thursday, while quarterly earnings missed analysts' estimates due to the ...

Detailed price information for Baxter International Inc (BAX-N) from The Globe and Mail including charting and trades.

Baxter International has voluntarily paused shipments and planned installations of its Novum infusion pump. In April, the FDA reported an underinfusion risk with the company’s Novum IQ large-volume ...

Baxter International on Monday named Andrew Hider, chief executive of Canadian automation solutions firm ATS Corp., its new ...

Baxter International Inc. closed 30.72% below its 52-week high of $40.49, which the company achieved on September 17th.